Former STAR PhD Fellow
Current position: Vice President
In 2000 I was employed at Novo Nordisk A/S as a research scientist. Being a doctor of veterinary medicine, with seven years of experience from a clinical practice and five years from another pharmaceutical company I had never really had the time to do a PhD. The STAR programme changed that by providing me with the funding to be enrolled as a PhD student at the University of Copenhagen, while holding a position as research scientist. My work was characterized by research support in existing projects in combination with protocols and intensive lab work to provide data for the hypothesis in my PhD project, which investigated the effects of recombinant activated factor VII (rFVIIa) in experimental models of haemostasis.
Thinking back on that time it was lots of fun. Multiple activities were going on at the same time - including the management of 4-5 technicians. I enjoyed working in the lab, getting hands-on experience and engaging in direct problem solving. At the same time this period was characterized by intense networking including internal and external collaborations. After two and half years I was able to submit my PhD thesis including four papers, of which two were published in peer-reviewed journals. At the same time I was appointed manager of a new research department specifically defined to work with pharmacology in haemostasis. At that time we were eight people in the department. Now - almost six years later – we are 22 employees.
My burning passion is research, but over the years my focus has changed from being a specialist and active research scientist to more managerial tasks. I have successfully supervised one PhD student (funded by the STAR programme) and she is now employed in my department. The STAR funding gave me the opportunity to obtain my PhD in invivo pharmacology and led the way to my present position heading a research department at Novo Nordisk.